- Home
- RPRX vs PKX Comparison
RPRX vs PKX Comparison
Compare RPRX & PKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- PKX
- Stock Information
- Founded
- RPRX 1996
- PKX 1968
- Country
- RPRX United States
- PKX South Korea
- Employees
- RPRX N/A
- PKX N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- PKX Steel/Iron Ore
- Sector
- RPRX Health Care
- PKX Industrials
- Exchange
- RPRX Nasdaq
- PKX Nasdaq
- Market Cap
- RPRX 16.2B
- PKX 15.4B
- IPO Year
- RPRX 2020
- PKX 1994
- Fundamental
- Price
- RPRX $39.23
- PKX $54.38
- Analyst Decision
- RPRX Strong Buy
- PKX
- Analyst Count
- RPRX 3
- PKX 0
- Target Price
- RPRX $46.00
- PKX N/A
- AVG Volume (30 Days)
- RPRX 3.8M
- PKX 138.0K
- Earning Date
- RPRX 11-05-2025
- PKX 10-27-2025
- Dividend Yield
- RPRX 2.24%
- PKX 1.94%
- EPS Growth
- RPRX N/A
- PKX N/A
- EPS
- RPRX 1.75
- PKX 4.24
- Revenue
- RPRX $2,349,844,000.00
- PKX $49,844,200,539.00
- Revenue This Year
- RPRX $36.16
- PKX N/A
- Revenue Next Year
- RPRX $2.04
- PKX $4.11
- P/E Ratio
- RPRX $22.41
- PKX $43.36
- Revenue Growth
- RPRX 3.70
- PKX N/A
- 52 Week Low
- RPRX $24.05
- PKX $39.40
- 52 Week High
- RPRX $41.24
- PKX $61.24
- Technical
- Relative Strength Index (RSI)
- RPRX 59.26
- PKX 54.78
- Support Level
- RPRX $38.39
- PKX $51.00
- Resistance Level
- RPRX $40.01
- PKX $55.35
- Average True Range (ATR)
- RPRX 1.26
- PKX 0.99
- MACD
- RPRX 0.12
- PKX -0.11
- Stochastic Oscillator
- RPRX 63.19
- PKX 47.57
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PKX POSCO Holdings Inc.
POSCO Holdings Inc is a holding company and operates through its subsidiaries. The company operates across four distinct segments. The first segment is the Steel Segment, which includes the production and sale of steel products. The second segment is the Infrastructure Business, which is further divided into three operations. The Trading Segment comprises trading and natural resource development activities. The Construction Segment involves the planning, designing, and construction of industrial plants, civil engineering projects, and buildings. The Logistics and Others Segment. The third segment is the Secondary Battery Materials Segment, and the fourth segment is the Others Segment.